ACT Capital Partners, L.P. — 13F Holdings & Portfolio

CIK 1875197 · latest 13F-HR filed 2026-11-06

ACT Capital Partners, L.P. manages $154.0M in 13F-reported U.S. long-equity assets across 58 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are CVX (9.95%), KRYS (9.07%), TGTX (8.59%).

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$154.0M

Long-equity book

Holdings
58

Distinct positions

Period
2026-09-30

Filed 2026-11-06

Q/Q Activity
—

no prior filing cached

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

1 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 65.6%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Oct 23, 2026.

Assets Under Management
$498.9M
Discretionary
$498.9M
Employees
10
Accounts
1,089
Address
521 COLLEGE STREET
ASHEVILLE, NC 28801
Phone
(828) 398-2802
Name Title / Status Ownership Type
ENGLISH, DOUGLAS, BARRY ControlMANAGING MEMBER
since Oct 2014
75% or moreIndividual
ENGLISH, JENNIFER, REALE ControlCHIEF COMPLIANCE OFFICER
since Oct 2014
Less than 5%Individual
JOHNSON, ROGER, WESLEY ControlMANAGING MEMBER
since Oct 2014
10–25%Individual

Top Adds (vs prior quarter)

  • —
Show all →

Top Trims

  • —
Show all →

New Positions

  • —
Show all →

Exited Positions

  • —
Show all →

ACT Capital Partners, L.P. Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 CHEVRON CORPORATION CVX 166764100 $15.3M 9.95% 75,000 SH
2 KRYSTAL BIOTECH INC KRYS 501147102 $14.0M 9.07% 42,000 SH
3 TG THERAPEUTICS INC TGTX 88322Q108 $13.2M 8.59% 237,200 SH
4 EXXONMOBIL HOLDINGS CORP XOM 30233Q108 $12.8M 8.30% 78,500 SH
5 AMAZON COM INC AMZN 023135106 $10.6M 6.88% 42,500 SH
6 ABIVAX SA ABVX 00370M103 $8.4M 5.47% 85,000 SH
7 VIKING THERAPEUTICS INC VKTX 92686J106 $7.2M 4.66% 220,200 SH
8 SK HYNIX INC SKHY 78392B206 $6.4M 4.15% 34,700 SH
9 ARROWHEAD PHARMACEUTICALS IN ARWR 04280A100 $6.2M 4.00% 94,000 SH
10 NEKTAR THERAPEUTICS NKTR 640268306 $5.5M 3.55% 90,400 SH
11 TESLA INC TSLA 88160R101 $5.3M 3.41% 14,800 SH
12 CELCUITY INC CELC 15102K100 $4.7M 3.03% 58,650 SH
13 MICRON TECHNOLOGY INC MU 595112103 $3.7M 2.42% 3,500 SH
14 NUVATION BIO INC NUVB 67080N101 $3.2M 2.11% 579,500 SH
15 PALVELLA THERAPEUTICS INC NE PVLA 697947109 $3.1M 2.02% 22,500 SH
16 ENERGY TRANSFER L P ET 29273V100 $2.6M 1.71% 133,100 SH
17 BLOOM ENERGY CORP BE 093712107 $2.5M 1.62% 9,000 SH
18 AST SPACEMOBILE INC ASTS 00217D100 $2.3M 1.49% 39,000 SH
19 FREEPORT MCMORAN INC FCX 35671D857 $2.3M 1.48% 32,500 SH
20 CAMECO CORP CCJ 13321L108 $2.2M 1.43% 25,400 SH
21 MINERALYS THERAPEUTICS INC MLYS 603170101 $2.2M 1.43% 87,400 SH
22 AXT INC AXTI 00246W103 $2.0M 1.27% 25,200 SH
23 CYBIN INC HELP 23256X407 $1.7M 1.08% 135,000 SH
24 CANDEL THERAPEUTICS INC CADL 137404109 $1.6M 1.02% 150,500 SH
25 SK HYNIX INC Call HXSCF 78392B906 $1.3M 0.84% 7,000 SH
26 AMBARELLA INC AMBA G037AX101 $1.2M 0.79% 17,400 SH
27 APPLIED OPTOELECTRONICS INC AAOI 03823U102 $1.2M 0.77% 12,000 SH
28 TESLA INC Call TSLA 88160R901 $1.1M 0.69% 3,000 SH
29 GRAYSCALE BITCOIN TRUST ETF GBTC 389637109 $994.7K 0.65% 15,400 SH
30 KURA ONCOLOGY INC KURA 50127T109 $981.0K 0.64% 91,600 SH
31 SAGIMET BIOSCIENCES INC SGMT 786700104 $592.8K 0.39% 60,000 SH
32 COMPASS PATHWAYS PLC CMPS 20451W101 $567.3K 0.37% 45,600 SH
33 VIR BIOTECHNOLOGY INC VIR 92764N102 $559.0K 0.36% 50,000 SH
34 ON SEMICONDUCTOR CORP ON 682189105 $553.5K 0.36% 7,200 SH
35 ALPHA COGNITION INC ACOG 02074J501 $463.5K 0.30% 51,500 SH
36 CEREBRAS SYSTEMS INC CBRS 15675D103 $444.1K 0.29% 2,500 SH
37 ADLAI NORTYE LTD ANL 00704R109 $430.4K 0.28% 24,400 SH
38 PALISADE BIO INC PALI 696389402 $415.1K 0.27% 307,500 SH
39 REGENXBIO INC RGNX 75901B107 $395.3K 0.26% 52,500 SH
40 NOKIA CORP NOK 654902204 $354.9K 0.23% 35,000 SH
41 UIPATH INC PATH 90364P105 $346.7K 0.23% 27,000 SH
42 KAZIA THERAPEUTICS LTD KZIA 48669G303 $335.8K 0.22% 35,000 SH
43 CORVUS PHARMACEUTICALS INC CRVS 221015100 $311.0K 0.20% 27,000 SH
44 ARCTURUS THERAPEUTICS HLDGS ARCT 03969T109 $308.0K 0.20% 22,500 SH
45 ONDAS INC ONDS 68236H204 $274.9K 0.18% 37,500 SH
46 KYVERNA THERAPEUTICS INC KYTX 501976104 $272.0K 0.18% 40,000 SH
47 KEEL INFRASTRUCTURE CORP KEEL 486917107 $263.0K 0.17% 74,500 SH
48 CHURCHILL CAP CORP XI CCXI G2131A108 $261.4K 0.17% 22,500 SH
49 ARKO PETE CORP APC 04124A100 $222.9K 0.14% 15,000 SH
50 X-ENERGY INC XE 98386P102 $177.2K 0.12% 12,500 SH
Filer Information
Address
100 WEST LANCASTER AVENUE
SUITE 110
WAYNE, PA 19087
Phone
(610) 688-2834
Filing Manager
ACT Capital Partners, L.P.
WAYNE, PA
Signatory
Fayth Ecker
Chief Compliance Officer